Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma

Brief Communication

Saved in:

Bibliographic Details
Main Authors:	Mai, Elias K. (Author) , Bertsch, Uta (Author) , Schlenzka, Jana (Author) , Hillengaß, Jens (Author) , Raab, Marc-Steffen (Author) , Merz, Maximilian (Author) , Bärtsch, Marc-Andrea (Author) , Jauch, Anna (Author) , Hose, Dirk (Author) , Goldschmidt, Hartmut (Author)
Format:	Article (Journal)
Language:	English
Published:	2019
In:	Leukemia Year: 2019, Volume: 33, Issue: 1, Pages: 258-261
ISSN:	1476-5551
DOI:	10.1038/s41375-018-0195-9
Online Access:	Verlag, Volltext: https://doi.org/10.1038/s41375-018-0195-9 Verlag, Volltext: https://www.nature.com/articles/s41375-018-0195-9
Author Notes:	Elias K. Mai, Thomas Hielscher, Uta Bertsch, Jana Schlenzka, Hans J. Salwender, Markus Munder, Christian Gerecke, Ulrich Dührsen, Peter Brossart, Kai Neben, Jens Hillengass, Marc S. Raab, Maximilian Merz, Marc-Andrea Baertsch, Anna Jauch, Dirk Hose, Hans Martin, Hans-Walter Lindemann, Igor W. Blau, Christof Scheid, Katja C. Weisel, Hartmut Goldschmidt, for the German-speaking Myeloma Multicenter Group (GMMG)

Description
Summary:	Brief Communication
Item Description:	Published online: 29 June 2018 Gesehen am 26.07.2019
Physical Description:	Online Resource
ISSN:	1476-5551
DOI:	10.1038/s41375-018-0195-9